HOME >> BIOLOGY >> NEWS
Vitamin A analog is a potential lung cancer preventative with few side effects

The ideal substance to prevent cancer would block tumor growth without causing unpleasant or dangerous side effects. Researchers at Washington University School of Medicine in St. Louis now report that a compound related to vitamin A shows promise in preventing or slowing tumor growth in mice prone to lung cancer. The compound, called bexarotene, doesn't cause the severe skin irritations that have limited the use of other vitamin A derivatives in cancer therapies.

"In the cancer prevention field, you look for drugs that can be given to healthy patients who have a higher risk of developing cancer," says Ming You, M.D., Ph.D., director of the Chemoprevention Program at the Siteman Cancer Center. "These patients wouldn't want to take a medication that makes them feel sick when they don't have cancer. So the drugs should be very well-tolerated and not cause harmful side effects."

In other studies, bexarotene showed some promise in cancer treatment. It extended survival in patients with non-small cell lung cancer, the most common type of lung cancer and one that has a five-year survival rate of less than 5 percent when diagnosed at the advanced stage.

In the current study, due to appear in an upcoming issue of Oncogene, Yian Wang, M.D., Ph.D., associate professor of surgery, You, professor of surgery, and colleagues demonstrate that lung-cancer-susceptible mice receiving non-toxic doses of bexarotene ended up with fewer and smaller benign and malignant tumors than mice that were not treated with bexarotene. The researchers saw a reduction of almost 50 percent in terms of total tumor burden in mice who were given bexarotene for 12 weeks after the animals had already developed benign tumors following injection of a lung carcinogen. Bexarotene also inhibited the progression of benign to malignant tumors by about 50 percent. The mice were engineered to have the genetic alterations seen in human lung cancers, so they readily develop lung cancer when given k
'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
17-Jan-2006


Page: 1 2 3

Related biology news :

1. Vitamin extends life in yeast, Dartmouth Medical School researchers find
2. Vitamin D, variations in its receptor and prostate cancer
3. Vitamin D deficiency widespread during pregnancy
4. Vitamin D3 provides the skin with protection from harmful microbes
5. Vitamin C and water not just healthy for people -- healthy for plastics, too
6. Vitamin D may cut pancreatic cancer risk by nearly half
7. Vitamin D and flavonoids examined for impact on breast and ovarian cancers
8. Nutritional friend or foe? Vitamin E sends mixed messages
9. Vitamin supplement could help treatment-resistant asthma
10. Vitamin As paradoxical role in influencing symmetry during embryonic development revealed
11. Vitamin E loss through smoking increases health risks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... 16, 2019 , ... LeadingBiotech , an exclusive event ... its NY/NJ CEO conference to be held on November 5, 2019 ... The event offers senior-level industry leaders a unique opportunity to collaborate, build partnerships ...
(Date:10/11/2019)... ... , ... Advanced Clinical, a clinical research services organization, is ... appointed Therapeutic Lead for Oncology. Dr. Tyan brings a wealth of practical, therapeutic, ... delivery credentials previously offered at Advanced Clinical. , Dr. Tyan has worked extensively ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a ... attendees of the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit ... 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare professionals from ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the ... is enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, ... veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in ...
(Date:10/3/2019)... (PRWEB) , ... October 02, 2019 , ... eKare’s inSight® ... NHS Digital Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), ... adoption of technology in NHS by providing support to develop and deploy solutions to ...
(Date:10/3/2019)... ... 2019 , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials ... Sherley, M.D., Ph.D., discussed important design factors that currently limit the success of early ... suppliers of clinical trials, in his talk Dr. Sherley focused on the ...
(Date:9/24/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... ... ... Pharma LLC will be presenting their latest research in the area of ... Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present ...
Breaking Biology Technology:
Cached News: